AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 130 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 3.37 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,126,000 | +125.2% | 32,688 | +9.2% | 0.59% | +149.4% |
Q2 2020 | $500,000 | +84.5% | 29,935 | +59.2% | 0.24% | +111.6% |
Q1 2020 | $271,000 | -60.3% | 18,800 | -7.8% | 0.11% | +0.9% |
Q4 2019 | $682,000 | +157.4% | 20,386 | +61.4% | 0.11% | +109.4% |
Q3 2019 | $265,000 | -4.7% | 12,634 | -5.3% | 0.05% | -10.2% |
Q2 2019 | $278,000 | +3.7% | 13,338 | +11.2% | 0.06% | -89.6% |
Q1 2019 | $268,000 | -18.0% | 11,993 | -12.4% | 0.57% | +917.9% |
Q4 2018 | $327,000 | -24.7% | 13,687 | -13.9% | 0.06% | +24.4% |
Q3 2018 | $434,000 | -40.8% | 15,893 | -41.7% | 0.04% | -93.1% |
Q2 2018 | $733,000 | +4.3% | 27,252 | +23.3% | 0.65% | +6.2% |
Q1 2018 | $703,000 | +79.8% | 22,101 | +113.8% | 0.61% | +24.2% |
Q4 2017 | $391,000 | -11.9% | 10,336 | -42.3% | 0.49% | +718.3% |
Q3 2017 | $444,000 | +32.9% | 17,898 | +10.1% | 0.06% | +20.0% |
Q2 2017 | $334,000 | +23.2% | 16,261 | +30.4% | 0.05% | +4.2% |
Q1 2017 | $271,000 | +17.3% | 12,472 | +10.6% | 0.05% | -30.4% |
Q4 2016 | $231,000 | -21.2% | 11,276 | -42.2% | 0.07% | -51.4% |
Q3 2016 | $293,000 | +38.9% | 19,501 | 0.0% | 0.14% | -9.6% |
Q2 2016 | $211,000 | +14.1% | 19,501 | +42.7% | 0.16% | -38.4% |
Q1 2016 | $185,000 | – | 13,666 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,295,712 | $47,524,000 | 3.98% |
Samsara BioCapital, LLC | 232,571 | $3,354,000 | 1.93% |
Eventide Asset Management | 3,851,000 | $55,531,000 | 1.80% |
Burrage Capital Management LLC | 112,546 | $1,609,000 | 1.58% |
Avidity Partners Management LP | 408,000 | $5,883,000 | 0.81% |
RICE HALL JAMES & ASSOCIATES, LLC | 982,484 | $14,167,000 | 0.79% |
Bullseye Asset Management LLC | 43,374 | $626,000 | 0.75% |
Nantahala Capital Management | 1,005,302 | $14,496,000 | 0.54% |
ARMISTICE CAPITAL, LLC | 600,000 | $8,652,000 | 0.54% |
Values First Advisors, Inc. | 27,042 | $389,947 | 0.47% |